Methods of administering/dosing antiRSV antibodies for prophylaxis and treatment

Details for Australian Patent Application No. 2008202076 (hide)

Owner MedImmune, LLC

Inventors Watkins, Jeffry; Huse, William; Wu, Herren; Koenig, Scott; Johnson, Leslie S.; Young, James F.

Agent Spruson & Ferguson

Pub. Number AU-B-2008202076

Parent 2002219944

Filing date 9 May 2008

Wipo publication date 29 May 2008

Acceptance publication date 8 September 2011

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

29 May 2008 Application Open to Public Inspection

  Published as AU-B-2008202076

29 May 2008 Complete Application Filed

2 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC Amendments

25 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

17 September 2009 Section 223 Application Received

  MedImmune, LLC An application to extend the time from 28 Nov 2008 to 28 Jun 2009 in which to pay a renewal fee has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Extensions of Time, Section 223

29 October 2009 Section 223 Application Allowed

  MedImmune, LLC The time in which to pay a renewal fee has been extended to 28 Jun 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Extensions of Time, Section 223 2009

8 September 2011 Application Accepted

  Published as AU-B-2008202076

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202077-Treatment of metal-containing water

2008202075-Temperature monitoring return electrode